Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...
Ocaliva, a farnesoid X receptor agonist, was withdrawn from the U.S. market due to FDA concerns about liver injury in patients. Initially approved in 2016 under an accelerated pathway, Ocaliva faced ...
To install the library, you can choose between two methods: TLS Requests is a cutting-edge HTTP client for Python, offering a feature-rich, highly configurable alternative to the popular requests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback